
FDA Watch: MeMed and NG Biotech Receive FDA Breakthrough Device Designations for Rapid Infection Tests
In both cases, the diagnostic tests report results back within 15 minutes

In both cases, the diagnostic tests report results back within 15 minutes

But anti-regulatory stance taken by Trump administration could serve as a potential obstacle in the effort

TruVerus is designed to perform a slew of clinical laboratory tests on as few as eight drops of blood

The two assays identify threats prior to prostate cancer being diagnosed and after it has undergone extensive treatment, respectively

San Diego-based healthcare diagnostics company is trying to succeed where Theranos failed